Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Vaccine Sales Are Falling. Should You Still Buy Pfizer?
02:00pm, Thursday, 04'th May 2023
Pfizer reported a 77% drop in vaccine sales in the first quarter and expects more declines to come. But the company may be heading into a new period of growth thanks to a record number of potential pr
Is This Incredibly Cheap, High-Yield Dividend Stock a Screaming Buy After Q1 Earnings?
11:00am, Wednesday, 03'rd May 2023
Declining demand for COVID-19 products and upcoming patent expirations have weighed on Pfizer's share price this year. As a result, the drugmaker's stock is now among the cheapest within its peer grou
Only 2 Companies Are AAA Rated As U.S. Risks Being A Deadbeat
08:00am, Wednesday, 03'rd May 2023
Lawmakers are playing chicken with the debt ceiling. Luckily there are still two U.S. S&P 500 companies left with AAA credit ratings.
Why Pfizer Is Among the Best High-Yield Dividend Stocks on the Market Now
05:52am, Wednesday, 03'rd May 2023
Pfizer offers an attractive dividend that's likely to continue growing. Its revenue growth prospects are also better than they might appear at first glance.
Pfizer Will Focus on Dividends and Buybacks, Execs Say
04:14pm, Tuesday, 02'nd May 2023
The drugmaker has been on an M&A hot streak over the past couple of years.
Pfizer (PFE) Q1 Earnings Beat, COVID Jab Sales Down as Expected
03:19pm, Tuesday, 02'nd May 2023
Pfizer (PFE) beats estimates for Q1 earnings and sales. Revenues from its COVID-19 vaccine, Comirnaty declined, as expected.
Covid will no longer be the epicenter of what we do, says Pfizer CEO Albert Bourla
03:14pm, Tuesday, 02'nd May 2023
Pfizer CEO Albert Bourla joins 'Power Lunch' to discuss the company's latest earnings report, the subsequent growth driver for pharmaceuticals, and more.
Pfizer CEO Albert Bourla comments on 2023 pipeline and Covid-19 products
02:32pm, Tuesday, 02'nd May 2023
Pfizer CEO Albert Bourla comments on 2023 pipeline and Covid-19 products.
Pfizer: Q1 earnings call key takeaways
01:28pm, Tuesday, 02'nd May 2023
Yahoo Finance's Anjalee Khemlani joins the Live show to provide key takeaways from Pfizer's first-quarter earnings call and to discuss the long-term outlook for the American multinational pharmaceutic
Market Eagerly Awaits Outcome of Fed FOMC Meet
12:57pm, Tuesday, 02'nd May 2023
Market Eagerly Awaits Outcome of Fed FOMC Meet.
JOLTS Data After the Bell, Q1 Reports for PFE, UBER & More
12:11pm, Tuesday, 02'nd May 2023
The JOLTS report for March will be out today, making it the first of several employment-related releases out this week.
Pfizer 1Q earnings top forecasts amid expected COVID vaccine sales slump
09:24am, Tuesday, 02'nd May 2023
Pfizer's first quarter earnings topped expectations despite a significant decline in its COVID-related sales during the first three months of 2023. The New York-based pharmaceutical giant reported a
Pfizer Reports Dramatic Declines — But It's Not As Bad As Wall Street Expected
08:50am, Tuesday, 02'nd May 2023
Pfizer reported double-digit declines across its first-quarter metrics, but beat analysts' expectations. Pfizer stock inched ahead.
Pfizer beats on top and bottom lines
08:10am, Tuesday, 02'nd May 2023
CNBC's Joe Kernen reports on Pfizer's quarterly earnings results.
Pfizer stock rallies toward 4-day win streak after big profit and revenue beats, reiterated outlook
07:03am, Tuesday, 02'nd May 2023
Shares of Pfizer Inc. PFE rallied 2.0% in premarket trading Tuesday, toward a 4th-straight gain and to extend its bounce off a 2-year low, after the drug maker reported first-quarter profit and revenu
